The Magazine for Sleep Professionals
Saturday, April 18, 2026
WatchPAT® with SleePATh® is a digital solution for clinicians which integrates automated subjective patient data with the WatchPAT® ONE home sleep study results for enhanced diagnosis, data management and analysis. It simplifies the patient journey, streamlines the clinical experience and enhances the diagnosis. It combines pre and post sleep study […]
ZOLL® Medical Corporation and Itamar™ Medical Ltd. announced that the two companies signed a definitive agreement under which ZOLL Medical will acquire all outstanding ordinary shares of Itamar Medical for a total value of approximately $538 million. Itamar Medical is focused on the development and commercialization of non-invasive medical devices […]
Itamar Medical Ltd., focused on the integration of sleep apnea management into the cardiac patient care pathway, announced that it has entered into a definitive agreement to acquire technology and assets of Spry Health for an undisclosed cash amount. Spry, based in the San Francisco Bay area, develops a wrist-based […]
Itamar Medical Ltd. announced that it has entered into an agreement with Sleep Data Diagnostics and its virtual-care platform BetterNight and Sleep Data Holdings, a leading provider of home-based positive airway pressure (PAP) services. This agreement is designed to radically simplify the process by which both sleep and non-sleep referring […]
Itamar Medical Ltd. today announced publication of results of the COMPASS study validating scoring guidelines that better enable physicians and respiratory technologists to review, verify and interpret WatchPAT automated scoring. The study also found that the use of those guidelines is reliable and improves agreement between WatchPAT and gold standard […]
Selection of Itamar’s WatchPAT home sleep apnea diagnostic system underscores the importance and significance of understanding sleep disorders to prevent and manage risk of heart disease and stroke Recognition that unique biological data collected from WatchPAT will be a valuable addition to the Project 10K database and its predictive medicine […]
Itamar Medical Ltd. has announced that Blue Shield of California (BSC) and the Blue Cross Blue Shield Federal Employee Plan (BCBS FEP) have included WatchPAT™ as a covered home sleep apnea diagnostic test. The Company also announced the release of the U.S. Centers for Medicare & Medicaid Services (CMS) 2020 […]
Latest WatchPAT innovation improves patient comfort and simplifies physician workflow Itamar Medical Ltd. today announced the launch of WatchPAT 300, the next generation WatchPAT system for home sleep apnea testing. WatchPAT 300 includes several advances that are designed to enhance both patients’ WatchPAT experience as well as provide physicians with a […]
Selection as one of the most prominent and important articles of 2018 reflects significant contribution to advancing cardiovascular health Itamar Medical Ltd. today announced that an article previously published in Circulation1 has been selected for inclusion in the journal’s 2018 Year in Review. This review, which appears in the February 2019 issue of Circulation: […]
Itamar Medical Ltd. today announced the release of the 2019 Fee Schedule from the U.S. Centers for Medicare & Medicaid Services (CMS) that should support broad use of its WatchPAT technology. WatchPAT is the only product on the market today that uses Peripheral Arterial Tone (PAT) technology, providing cardiologists and […]
